Tumor angiogenesis and p53 mutations: Prognosis in head and neck cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 124, Issue 1, 1998, Pages 80-85

  Hegde, Poornima U ^a   Brenski, Amy C ^a   Caldarelli, David D ^a   Hutchinson, James ^a   Panje, William R ^a   Wood, Nancy B ^a   Leurgans, Sue ^a   Preisler, Harvey D ^b   Taylor IV, Samuel G ^b   Caldarelli, Leslie ^a   Coon, John S ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; EXON; GENE MUTATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

EID: 6844237661     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.124.1.80     Document Type: Article

References (26)

1. Folkman J, Long DM, Backer FF. Growth and metastasis of tumor in organ culture. Cancer. 1963;16:453.
2. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990;82:4-6.
3. Weidner N. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
4. Weidner N. Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst. 1992;84:1875-1887.
5. Bosari S. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol. 1992;23:755-761.
6. Revesz L, Siracka E, Siracky J, Delides G, Pavlaki K. Variation of vascular density within and between tumors of the uterine cervix and its predictive value for radiotherapy, Int J Radiation Oncol Biol Phys. 1989;16:1161-1163.
7. Delides GS, Venizelos J, Revesz L. Vascularization and curability of nasopharyneal tumors in stage III and IV. Cancer Res Clin Oncol. 1988;114:321-323.
8. Zatterstrom UK, Brun E, Willen R, Kjellen E, Wennerberg J. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck. 1995;17:312-318.
9. Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54:4855-4878.
10. Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 1991;88:5413-5417.
11. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993;53:4477-4480.
12. Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 1994;265:1582-1584.
13. Wood NB, Kotelnikov V, Caldarelli D, et al. Mutation of p53 correlates with rapid tumor proliferation and poor survival in squamous cell cancer of the head and neck. Laryngoscope. 1997;107:827-833.
14. Lingen MW, Polverini PJ, Bouck NP. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am J Pathol. 1996; 149:247-258.
15. Petruzzelli GJ, Johnson JT, Snyderman CH, Myers EN. Angiogenesis induced by head and neck squamous cell carcinoma xenografts in the chick embryo chorioallantoic membrane model. Ann Otol Rhinol Laryngol. 1993;102:215-221.
16. Hsu SC, Volpert OV, Steck PA, et al. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res. 1996; 56:5684-5691.
17. Gasparini G, Weidner N, Bevilacqua P, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol. 1994;12:454-466.
18. Leedy DA, Trune DR, Kronz JD, Weidner N, Cohen JI. Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous cell carcinoma of the tongue. Otolaryngol Head Neck Surg. 1994;111:417-422.
19. Gasparini G, Fox SB, Verderio P, et al. Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients. Clin Cancer Res. 1996;2:1191-1198.
20. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count and computer image analysis. J Pathol. 1995; 177:275-283.
21. Ottinetti A, Sapino A. Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions. Breast Cancer Res Treat. 1988;11: 241-248.
22. Williams JK, Carlson GW, Cohen C, Derose PD, Hunter S, Jurkiewicz MJ. Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg. 1994;168: 373-380.
23. Wakui S, Furusato M, Itoh T, et al. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol. 1992; 168:257-262.
24. Frank RE, Saclarides TJ, Leurgans S, Speziale NJ, Drab EA, Rubin DB. Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg. 1995;222:695-699.
25. Ueba T, Nosaka T, Takahashi JA, et al. Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells. Proc Natl Acad Sci U S A. 1994;91:9009-9013.
26. Siracka E, Revesz L, Kovac R, Siracky J. Vascular density in carcinoma of the uterine cervix and its predictive value for radiotherapy, Int J Cancer. 1988;41: 819-822.